{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:39:22Z","timestamp":1786790362174,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation program","award":["HAP2 - number 847782"],"award-info":[{"award-number":["HAP2 - number 847782"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05946-6","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:53:34Z","timestamp":1773302014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of a robust metabolic signature associated with hospital-acquired pneumonia and response to interferon-gamma treatment in critically ill patients"],"prefix":"10.1186","volume":"30","author":[{"given":"Melanie","family":"Petrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Flattres Duchaussoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hurtado-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00edsa V","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost H. A.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Koulenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Fern\u00e1ndez-Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Montassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Poschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roquilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"5946_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jinf.2012.06.016","volume":"65","author":"J-D Ricard","year":"2012","unstructured":"Ricard J-D, Conti G, Boucherie M, Hormann C, Poelaert J, Quintel M, et al. A European survey of nosocomial infection control and hospital-acquired pneumonia prevention practices. J Infection. 2012;65:285\u201391. https:\/\/doi.org\/10.1016\/j.jinf.2012.06.016.","journal-title":"J Infection."},{"key":"5946_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2022.101184","volume":"42","author":"M Garnier","year":"2023","unstructured":"Garnier M, Constantin J-M, Heming N, Camous L, Ferr\u00e9 A, Razazi K, et al. Epidemiology, risk factors and prognosis of ventilator-associated pneumonia during severe COVID-19: Multicenter observational study across 149 European Intensive Care Units. Anaesth Crit Care Pain Med. 2023;42:101184. https:\/\/doi.org\/10.1016\/j.accpm.2022.101184.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"5946_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/jac\/dkad094","volume":"78","author":"C Lagarde","year":"2023","unstructured":"Lagarde C, Bouras M, Floch RL, Hourmant Y, Grillot N, Bourdiol A, et al. A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections\u2014a monocentre quality improvement project. J Antimicrob Chemother. 2023;78:1378\u201385. https:\/\/doi.org\/10.1093\/jac\/dkad094.","journal-title":"J Antimicrob Chemother"},{"key":"5946_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2024.101353","volume":"43","author":"C Poulain","year":"2024","unstructured":"Poulain C, Launey Y, Bouras M, Lakhal K, Dargelos L, Cr\u00e9met L, et al. Clinical evaluation of the BioFire Respiratory Pathogen Panel for the guidance of empirical antimicrobial therapy in critically ill patients with hospital-acquired pneumonia: A multicenter, quality improvement project. Anaesth Crit Care Pain Med. 2024;43:101353. https:\/\/doi.org\/10.1016\/j.accpm.2024.101353.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"5946_CR5","doi-asserted-by":"publisher","first-page":"e1601","DOI":"10.1093\/cid\/ciaa1441","volume":"73","author":"A Roquilly","year":"2020","unstructured":"Roquilly A, Chanques G, Lasocki S, Foucrier A, Fermier B, Courson HD, et al. Implementation of French Recommendations for the Prevention and the Treatment of Hospital-acquired Pneumonia: A Cluster-randomized Trial. Clin Infect Dis. 2020;73:e1601\u201310. https:\/\/doi.org\/10.1093\/cid\/ciaa1441.","journal-title":"Clin Infect Dis"},{"key":"5946_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1164\/rccm.202110-2324oc","volume":"206","author":"T Chaumette","year":"2022","unstructured":"Chaumette T, Cinotti R, Moll\u00e9 A, Solomon P, Castain L, Fourgeux C, et al. Monocyte Signature Associated with Herpes Simplex Virus Reactivation and Neurological Recovery after Brain Injury. Am J Resp Crit Care. 2022;206:295\u2013310. https:\/\/doi.org\/10.1164\/rccm.202110-2324oc.","journal-title":"Am J Resp Crit Care."},{"key":"5946_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.165","author":"F Venet","year":"2017","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2017. https:\/\/doi.org\/10.1038\/nrneph.2017.165.","journal-title":"Nat Rev Nephrol"},{"key":"5946_CR8","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/s1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19:e422\u201336. https:\/\/doi.org\/10.1016\/s1473-3099(19)30567-5.","journal-title":"Lancet Infect Dis"},{"key":"5946_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25:19\u201328. https:\/\/doi.org\/10.1038\/s41590-023-01660-5.","journal-title":"Nat Immunol"},{"key":"5946_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00134-023-07065-0","volume":"49","author":"A Roquilly","year":"2023","unstructured":"Roquilly A, Francois B, Huet O, Launey Y, Lasocki S, Weiss E, et al. Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial. Intensiv Care Med. 2023;49:530\u201344. https:\/\/doi.org\/10.1007\/s00134-023-07065-0.","journal-title":"Intensiv Care Med."},{"key":"5946_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00134-025-07884-3","volume":"51","author":"FP Martin","year":"2025","unstructured":"Martin FP, Poulain C, Mulier JH, Motos A, Gourain V, Ogan I, et al. Identification and validation of robust hospital-acquired pneumonia subphenotypes associated with all-cause mortality: a multi-cohort derivation and validation. Intensive Care Med. 2025;51:692\u2013707. https:\/\/doi.org\/10.1007\/s00134-025-07884-3.","journal-title":"Intensive Care Med"},{"key":"5946_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01534-z","volume":"15","author":"D Thomas-R\u00fcddel","year":"2025","unstructured":"Thomas-R\u00fcddel D, Giamarellos-Bourboulis E, Neumann C, Briegel J, Roquilly A, Annane D, et al. IFN\u03b3 in human sepsis: a scoping review. Ann Intensive Care. 2025;15:112. https:\/\/doi.org\/10.1186\/s13613-025-01534-z.","journal-title":"Ann Intensive Care"},{"key":"5946_CR13","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1038\/s41591-023-02617-9","volume":"29","author":"E Montassier","year":"2023","unstructured":"Montassier E, Kitsios GD, Radder JE, Bastard QL, Kelly BJ, Panzer A, et al. Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia. Nat Med. 2023;29:2793\u2013804. https:\/\/doi.org\/10.1038\/s41591-023-02617-9.","journal-title":"Nat Med"},{"key":"5946_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41590-020-0673-x","volume":"21","author":"A Roquilly","year":"2020","unstructured":"Roquilly A, Jacqueline C, Davieau M, Moll\u00e9 A, Sadek A, Fourgeux C, et al. Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat Immunol. 2020;21:636\u201348. https:\/\/doi.org\/10.1038\/s41590-020-0673-x.","journal-title":"Nat Immunol"},{"key":"5946_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.immuni.2017.06.021","volume":"47","author":"A Roquilly","year":"2017","unstructured":"Roquilly A, McWilliam HEG, Jacqueline C, Tian Z, Cinotti R, Rimbert M, et al. Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity. 2017;47:135-147.e5. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.021.","journal-title":"Immunity"},{"key":"5946_CR16","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594\u2013605. https:\/\/doi.org\/10.1001\/jama.2011.1829.","journal-title":"JAMA"},{"key":"5946_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/nri3552","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013. https:\/\/doi.org\/10.1038\/nri3552.","journal-title":"Nat Rev Immunol"},{"key":"5946_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"S-C Cheng","year":"2016","unstructured":"Cheng S-C, Scicluna BP, Arts RJW, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ, et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol. 2016;17:406\u201313. https:\/\/doi.org\/10.1038\/ni.3398.","journal-title":"Nat Immunol"},{"key":"5946_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07248-9","author":"S Cao","year":"2023","unstructured":"Cao S, Li H, Xin J, Jin Z, Zhang Z, Li J, et al. Identification of genetic profile and biomarkers involved in acute respiratory distress syndrome. Intensiv Care Med. 2023. https:\/\/doi.org\/10.1007\/s00134-023-07248-9.","journal-title":"Intensiv Care Med."},{"key":"5946_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/s2213-2600(19)30140-7","volume":"7","author":"A Roquilly","year":"2019","unstructured":"Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, et al. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med. 2019;7:710\u201320. https:\/\/doi.org\/10.1016\/s2213-2600(19)30140-7.","journal-title":"Lancet Respir Med"},{"key":"5946_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1809700115","volume":"115","author":"C Langelier","year":"2018","unstructured":"Langelier C, Kalantar KL, Moazed F, Wilson MR, Crawford ED, Deiss T, et al. Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proc Natl Acad Sci U S A. 2018;115:201809700. https:\/\/doi.org\/10.1073\/pnas.1809700115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5946_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-07859-4","author":"DB Antcliffe","year":"2025","unstructured":"Antcliffe DB, Harte E, Hussain H, Jim\u00e9nez B, Browning C, Gordon AC. Metabolic septic shock sub-phenotypes, stability over time and association with clinical outcome. Intensiv Care Med. 2025. https:\/\/doi.org\/10.1007\/s00134-025-07859-4.","journal-title":"Intensiv Care Med."},{"key":"5946_CR23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT). Eur Respir J. 2017;50:1700582. https:\/\/doi.org\/10.1183\/13993003.00582-2017.","journal-title":"Eur Respir J"},{"key":"5946_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.accpm.2017.11.006","volume":"37","author":"M Leone","year":"2018","unstructured":"Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, et al. Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med. 2018;37:83\u201398. https:\/\/doi.org\/10.1016\/j.accpm.2017.11.006.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"5946_CR25","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307:2526\u201333. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"key":"5946_CR26","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. 2012;2526--2533."},{"key":"5946_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00216-011-4929-z","volume":"401","author":"S-O Deininger","year":"2011","unstructured":"Deininger S-O, Cornett DS, Paape R, Becker M, Pineau C, Rauser S, et al. Normalization in MALDI-TOF imaging datasets of proteins: practical considerations. Anal Bioanal Chem. 2011;401:167\u201381. https:\/\/doi.org\/10.1007\/s00216-011-4929-z.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"5946_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2023.12.005","volume":"57","author":"SJCFM Moorlag","year":"2024","unstructured":"Moorlag SJCFM, Folkman L, ter Horst R, Krausgruber T, Barreca D, Schuster LC, et al. Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity. Immunity. 2024;57(1):171\u201387.","journal-title":"Immunity"},{"key":"5946_CR29","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","volume":"188","author":"A Ziogas","year":"2025","unstructured":"Ziogas A, Novakovic B, Ventriglia L, Galang N, Tran KA, Li W, et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell. 2025;188:2992-3012.e16. https:\/\/doi.org\/10.1016\/j.cell.2025.03.048.","journal-title":"Cell"},{"key":"5946_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae137","author":"J Hagenberg","year":"2024","unstructured":"Hagenberg J, Budde M, Pandeva T, Kondofersky I, Schaupp SK, Theis FJ, et al. longmixr: a tool for robust clustering of high-dimensional cross-sectional and longitudinal variables of mixed data types. Bioinformatics. 2024. https:\/\/doi.org\/10.1093\/bioinformatics\/btae137.","journal-title":"Bioinformatics"},{"key":"5946_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"key":"5946_CR32","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/cid\/ciz093","volume":"69","author":"E Weiss","year":"2019","unstructured":"Weiss E, Zahar J-R, Alder J, Asehnoune K, Bassetti M, Bonten MJM, et al. Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired\/Ventilator-associated Bacterial Pneumonia Clinical Trials. Clin Infect Dis Official Publ Infect Dis Soc Am. 2019;69:1912\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz093.","journal-title":"Clin Infect Dis Official Publ Infect Dis Soc Am."},{"key":"5946_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.20020092","volume":"196","author":"NY Crowe","year":"2002","unstructured":"Crowe NY, Smyth MJ, Godfrey DI. A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas. J Exp Medicine. 2002;196:119\u201327. https:\/\/doi.org\/10.1084\/jem.20020092.","journal-title":"J Exp Medicine."},{"key":"5946_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00134-015-4077-6","volume":"42","author":"JJ Cast\u00f3n","year":"2016","unstructured":"Cast\u00f3n JJ, Cantis\u00e1n S, Gonz\u00e1lez-Gasca F, P\u00e1ez-Vega A, Abdel-Hadi H, Illescas S, et al. Interferon-\u03b3 production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients. Intensiv Care Med. 2016;42:46\u201353. https:\/\/doi.org\/10.1007\/s00134-015-4077-6.","journal-title":"Intensiv Care Med."},{"key":"5946_CR35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12879-019-4526-x","volume":"19","author":"D Payen","year":"2019","unstructured":"Payen D, Faivre V, Miatello J, Leentjens J, Brumpt C, Tissi\u00e8res P, et al. Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series BMC Infect Dis. 2019;19:931. https:\/\/doi.org\/10.1186\/s12879-019-4526-x.","journal-title":"A case series. BMC Infect Dis."},{"key":"5946_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067251","volume":"12","author":"A Kotsaki","year":"2022","unstructured":"Kotsaki A, Pickkers P, Bauer M, Calandra T, Lupse M, Wiersinga WJ, et al. ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol. BMJ Open. 2022;12:e067251. https:\/\/doi.org\/10.1136\/bmjopen-2022-067251.","journal-title":"BMJ Open"},{"key":"5946_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105414","volume":"109","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Antonelli M, Bloos F, Kotsamidi I, Psarrakis C, Dakou K, et al. Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality. EBioMedicine. 2024;109:105414. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105414.","journal-title":"EBioMedicine"},{"key":"5946_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, et al. Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial. Cell Rep Med. 2022;3:100817. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100817.","journal-title":"Cell Rep Med"},{"key":"5946_CR39","doi-asserted-by":"publisher","unstructured":"Wyngene LV, Vandewalle J, Libert C. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med. 2018. https:\/\/doi.org\/10.15252\/emmm.201708712","DOI":"10.15252\/emmm.201708712"},{"key":"5946_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2025.101535","volume":"44","author":"S Andrei","year":"2025","unstructured":"Andrei S, Meilhac O, Tymowski CD, Snauwaert A, Stern J, Robert T, et al. Relationship between high-density lipoprotein cholesterol (HDL-C) concentration and ventilator-associated pneumonia in ICU COVID-19 patients. Anaesth Crit Care Pain Med. 2025;44:101535. https:\/\/doi.org\/10.1016\/j.accpm.2025.101535.","journal-title":"Anaesth Crit Care Pain Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05946-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05946-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05946-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:48:47Z","timestamp":1776674927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05946-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5946"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05946-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection of human samples within IBIS has been declared to the French Ministry of Health (Programme de recherche \u201cImmunologie\u201d, DC2014-2206, authorization renewed DC-2017-2987) and was approved by the Comit\u00e9 de Protection des Personnes Ouest IV (7\/04\/2015 and 08\/10\/2020, number clinicaltrial.gov NCT02003196). The CERAR (Ethics Committee for Anesthesiology and Intensive Care Research) approved this secondary analysis protocol under the reference number IRB 00010254 \u2013 2020 - 041. The PREV-HAP study protocol was approved by the Ouest II Angers (France) Ethics Committee in March 2021. All patients or their legal representatives consented to the use of data and samples for this study, as appropriate under national legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the authors revised the final manuscript version and approved its submission for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}